GU Oncology Now Contributors and Partners
EDITORIAL ADVISORY BOARD
EDITORS
Brian Rini, MD, FASCO, is chief of clinical trials and Ingram Professor of Medicine in the Hematology and Oncology division at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. He serves as co-host of The Uromigos podcast along with Dr. Thomas Powles.
Thomas Powles, MBBS, MRCP, MD, is a professor of genitourinary oncology as well as the director of Barts Cancer Centre at St. Bartholomew’s Hospital. He is also the hospital’s Lead for Solid Tumour Research. Dr. Powles serves as co-host of The Uromigos podcast along with Dr. Brian Rini.
Kathryn Beckermann, MD, PhD, is the Medical Director of GU Clinical Research at Tennessee Oncology. She is a GU medical oncologist specialized in treating kidney, bladder, prostate, and testicular cancer.
Christopher Wallis, MD, PhD, FRCSC, is an Assistant Professor in the Division of Urology at the University of Toronto. He is also a urologic oncologist in the Division of Urology at Mount Sinai Hospital and University Health Network.
David Ambinder, MD, is a urology resident at New York Medical College/Westchester Medical Center. His interests include surgical education, GU oncology, and advancements in technology in urology. A significant portion of his research has been focused on litigation in urology.
Akhil Abraham Saji, MD, is a urologist specializing in minimally invasive surgery and urologic oncology with an interest in technology-driven innovation within health care.
GU ONCOLOGY NOW EDITORIAL STAFF
MANAGING EDITOR
Zachary Bessette, [email protected]
EDITOR
Jessica Ganga, [email protected]
ASSOCIATE EDITOR
Emily Menendez, [email protected]
ASSISTANT ART DIRECTOR
John Salesi, [email protected]
PARTNERS
The Uromigos
The Uromigos podcast, hosted by Thomas Powles, professor of genitourinary oncology at Barts Cancer Centre, and Brian Rini, Ingram Professor of Medicine at Vanderbilt-Ingram Cancer Center, broadcasts the latest developments in GU cancer. Each episode features fascinating discussions with leading experts from around the world and dives into the data and clinical news relevant to the care of GU oncology patients. In their “Legends of GU Oncology” series, the podcasting duo focuses on the founders of the field.